Clinical Trial Update: Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 clinical study assessing SR-T100 Topical Gel for actinic keratosis and Bowen's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis
• Bowen Disease

Drugs mentioned

• SR-T100 Topical Gel

Snippet

Sponsor: G&E Herbal Biotechnology Co., LTD | Conditions: Actinic Keratosis, Bowen's Disease | Phase 2 | Status: COMPLETED